Skin Rash – Friday Pop Quiz 6/23/2023
177171771717717
Which of the following treatments for the shown rash with 15% body surface area (BSA) involvement is least likely to be associated with an infection?
A. Methotrexate
B. Cyclosporine
C. Adalimumab
D. Infliximab
E. Acitretin
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
…
Which of the following treatments for the shown rash with 15% body surface area (BSA) involvement is least likely to be associated with an infection?
A. Methotrexate
B. Cyclosporine
C. Adalimumab
D. Infliximab
E. Acitretin
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
… 
Before we dive into our discussion, let’s outline the Guideline-Based Approach to Treatment Selection.
The International Psoriasis Council has divided psoriasis treatment classification into 2 groups:
Patients who are a candidate for topical therapy, or
Patients who are a candidate for systemic therapy
Candidates for systemic therapy must meet at least 1 of the following … 
Next Steps in Derm and the Journal of Drugs in Dermatology, in partnership with the Dermatology Education Foundation (DEF) and Physicians Resources, interviewed board-certified dermatologist and dermatologic surgeon Dr. Brad Glick on his approach to patients with cutaneous signs of systemic disease.
Watch as he shares many examples of common and less common systemic diseases with dermatolog … 
Verrucous psoriasis (VP) is a rare histologic variant of psoriasis. To date, fewer than 40 cases have been reported, with pediatric cases representing an exceedingly small fraction. Treatment options are limited, and the disease is often refractory to conventional methods. Herein, JDD authors Samantha Sherkin OMS-IV, Christian Summa OMS-IV, David Crasto DO, Zackary Whitney DO, Lazlo Karai MD PhD,� … 
Dermatologists are prescribing oral glucocorticoids for psoriasis despite awareness of risks of life-threatening generalized pustular psoriasis (GPP) and erythrodermic psoriasis (EP). A recent survey of dermatologists published in the Journal of Drugs in Dermatology found 18% of respondents occasionally prescribe oral glucocorticoids to patients with psoriasis, typically 1-5% of the time. Those wh … 